—

BioNTech SE (BNTX) — Technical state

As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 35 out of 100 (momentum 41 · quality 22 · valuation 54), as of 2026-11-17.
  • Signal: Death cross — Its 50-day crossed below its 200-day 10 sessions ago — a death cross, the classic trend-turn-lower. (as of 2026-11-13)
  • Trend: BioNTech SE trades 8.0% below its 50-day and 10.6% below its 200-day moving average. (as of 2026-11-13)
  • Index seat: Euro-AI 50

BioNTech develops immunotherapies, best known for its mRNA-based vaccine against SARS-CoV-2. It also runs a broad oncology pipeline spanning lung, breast, colorectal and other solid tumours, alongside infectious-disease candidates for influenza, tuberculosis and malaria.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BNTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Death cross

Its 50-day crossed below its 200-day 10 sessions ago — a death cross, the classic trend-turn-lower.

The moving-average stack

FAQ · from the current data · as of 2026-11-13

Quick answers

What is the current Closelooknet signal on BNTX?

Death cross — Its 50-day crossed below its 200-day 10 sessions ago — a death cross, the classic trend-turn-lower. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BNTX above its 50-day and 200-day moving averages?

As of 2026-11-13, BioNTech SE trades -8% below its 50-day and -10.6% below its 200-day average, with the 20-day -2.7% away.

How far is BNTX from its 52-week high?

31% below the 52-week high and 7.6% above the 52-week low, as of 2026-11-13.

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.